FeedsFarm.com > ChemGenex Personalized Medicine Clinical Trial Expanded to Patients with Breast and Ovarian Cancers

Source:

Mammography News from StratCenter.com

Language:

English

Domain:

www.myhealthcarenews.com

More feeds from myhealthcarenews.com:

• Distribution/ Logistics News from StratCenter.com
• FDA News News from StratCenter.com
• Government/ Industry Regulation News from StratCenter.com
• Group Purchasing Related News from StratCenter.com
• Information Technologies/ MIS/ HIS News from StratCenter.com
• Nephrology/ Dialysis News from StratCenter.com
• Patient Monitoring News from StratCenter.com
• Physician News News from StratCenter.com
• Positron Emission Tomography (PET) News from StratCenter.com
• Surgery News from StratCenter.com

Search myhealthcarenews.com:

ChemGenex Personalized Medicine Clinical Trial Expanded to Patients with Breast and Ovarian Cancers

27th Sep 2005, 14:21 GMT

ChemGenex Pharmaceuticals announced that the Phase 2 clinical trial of its investigational anti-cancer drug, Quinamed, has been expanded to include patients with breast and ovarian cancer.

Latest news from Mammography News from StratCenter.com:

• Provectus Comments on 2006 Q3 Results
• iCAD to Unveil New Product Capabilities at Radiological Society of North America Annual Meeting
• FDA Panel Looks at J&J Cancer Test